<- Go Home
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. was acquired by Elan Corp. plc. Dura Pharmaceuticals, Inc. engages in the development, marketing, and sale of prescription pharmaceutical products for the treatment of allergies. The company was formerly known as Immunetech Pharmaceuticals, Inc. and changed its name to Dura Pharmaceuticals, Inc. in December, 1991. Dura Pharmaceuticals, Inc. was founded in 1981 and is based in San Diego, California.
Market Cap
$1.4B
Volume
737.6K
Cash and Equivalents
$80.3M
EBITDA
$71.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$214.0M
Profit Margin
65.22%
52 Week High
$39.50
52 Week Low
$11.00
Dividend
N/A
Price / Book Value
3.60
Price / Earnings
-21.30
Price / Tangible Book Value
-83.94
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$38.1M
Return on Equity
15.84%
Return on Assets
2.75
Cash and Short Term Investments
$250.2M
Debt
$287.5M
Equity
$399.0M
Revenue
$328.1M
Unlevered FCF
$70.0M
Sector
Pharmaceuticals
Category
N/A